Bionik Laboratories Corp. (BNKL) Financial Statements (2024 and earlier)

Company Profile

Business Address 80 COOLIDGE HILL ROAD
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End March 31
Industry (SIC) 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2023
3/31/2022
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,9916082,270447507544
Cash and cash equivalents1,9916082,270447507544
Receivables2754528651,542232403
Inventory, net of allowances, customer advances and progress billings1,1916921,059406237228
Inventory1,1916921,059406237228
Prepaid expense1,1271,68110411846160
Other undisclosed current assets   1,5291,23738868
Total current assets:4,5853,4335,8273,7491,4101,403
Noncurrent Assets
Operating lease, right-of-use asset   
Property, plant and equipment9194154193160227
Intangible assets, net (including goodwill) 5,26012,53626,73627,01527,339
Goodwill 4,28311,08622,30822,30822,308
Intangible assets, net (excluding goodwill) 9771,4504,4284,7075,031
Other noncurrent assets      
Total noncurrent assets:915,35312,69026,92927,17527,566
TOTAL ASSETS:4,6768,78618,51730,67828,58528,969
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,1781,2152,5052,8022,2542,013
Accounts payable3054558571,149725785
Accrued liabilities8737601,6481,6531,5301,229
Deferred revenue314268616
Debt  2,1522,079 51567
Deferred revenue and credits12399
Customer advances and deposits1122
Other undisclosed current liabilities 460 4685,6932,977
Total current liabilities:1,4924,0955,2003,2708,1225,778
Noncurrent Liabilities
Long-term debt and lease obligation 1,106    
Long-term debt, excluding current maturities 1,106    
Liabilities, other than long-term debt257304    
Deferred revenue257304 
Operating lease, liability   
Total noncurrent liabilities:2571,410    
Total liabilities:1,7495,5055,2003,2708,1225,778
Equity
Equity, attributable to parent2,9273,28113,31727,40820,46323,191
Common stock765425097
Additional paid in capital98,29588,22884,64473,71955,94838,641
Accumulated other comprehensive income284242424242
Accumulated deficit(95,402)(84,994)(71,374)(46,357)(35,776)(15,589)
Total equity:2,9273,28113,31727,40820,46323,191
TOTAL LIABILITIES AND EQUITY:4,6768,78618,51730,67828,58528,969

Income Statement (P&L) ($ in thousands)

3/31/2023
3/31/2022
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
Revenues1,2741,19310073987572
Revenue, net987572
Other operating income   10073  
Cost of revenue(320)(270)(893)(1,630)(403)(389)
Cost of goods and services sold   (893)(1,630)(403)(389)
Other undisclosed gross profit   2,0533,173  
Gross profit:9539241,2601,616585183
Operating expenses(10,926)(14,261)(12,424)(11,103)(10,354)(8,829)
Operating loss:(9,973)(13,337)(11,164)(9,487)(9,769)(8,646)
Nonoperating income (expense)(435)(282)(13,852)(1,069)(4,857)8,886
Investment income, nonoperating  1   4,176
Other nonoperating income (expense) (435)(283)(13,852)(1,069)(4,857)4,710
Interest and debt expense460(405) 338(1,297)(44)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  404 (338)1,297(4,133)
Loss from continuing operations before equity method investments, income taxes:(9,948)(13,620)(25,016)(10,557)(14,626)(3,937)
Other undisclosed income (loss) from continuing operations before income taxes(460)     
Loss from continuing operations:(10,408)(13,620)(25,016)(10,557)(14,626)(3,937)
Loss before gain (loss) on sale of properties:(10,408)(13,620)(25,016)(10,557)(14,626)(3,937)
Other undisclosed net income  50,033   
Net income (loss):(10,408)(13,620)25,016(10,557)(14,626)(3,937)
Other undisclosed net income attributable to parent    21,113  
Net income (loss) available to common stockholders, diluted:(10,408)(13,620)25,01610,557(14,626)(3,937)

Comprehensive Income ($ in thousands)

3/31/2023
3/31/2022
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
Net income (loss):(10,408)(13,620)25,016(10,557)(14,626)(3,937)
Comprehensive income (loss):(10,408)(13,620)25,016(10,557)(14,626)(3,937)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(14) (50,033)   
Comprehensive loss, net of tax, attributable to parent:(10,422)(13,620)(25,016)(10,557)(14,626)(3,937)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: